Ontario Teachers Pension Plan Board Lowers Holdings in Humana Inc. (NYSE:HUM)

Ontario Teachers Pension Plan Board reduced its holdings in Humana Inc. (NYSE:HUM - Free Report) by 47.7% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 614,079 shares of the insurance provider's stock after selling 559,456 shares during the quarter. Humana comprises 1.9% of Ontario Teachers Pension Plan Board's investment portfolio, making the stock its 17th largest position. Ontario Teachers Pension Plan Board owned approximately 0.51% of Humana worth $155,798,000 as of its most recent SEC filing.

Other hedge funds have also recently made changes to their positions in the company. Vanguard Group Inc. grew its holdings in shares of Humana by 15.8% during the 4th quarter. Vanguard Group Inc. now owns 12,829,210 shares of the insurance provider's stock worth $3,254,899,000 after acquiring an additional 1,751,857 shares during the period. Norges Bank bought a new stake in shares of Humana during the fourth quarter valued at approximately $416,202,000. Pzena Investment Management LLC grew its stake in Humana by 44.0% in the fourth quarter. Pzena Investment Management LLC now owns 3,609,382 shares of the insurance provider's stock worth $915,736,000 after purchasing an additional 1,103,132 shares during the period. Boston Partners raised its holdings in Humana by 435.8% in the fourth quarter. Boston Partners now owns 1,098,702 shares of the insurance provider's stock worth $279,236,000 after purchasing an additional 893,637 shares in the last quarter. Finally, Invesco Ltd. lifted its position in Humana by 29.8% during the fourth quarter. Invesco Ltd. now owns 2,397,808 shares of the insurance provider's stock valued at $608,348,000 after buying an additional 550,692 shares during the period. 92.38% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of analysts have recently weighed in on HUM shares. Robert W. Baird upped their target price on shares of Humana from $270.00 to $300.00 and gave the stock a "neutral" rating in a research report on Tuesday, April 15th. Guggenheim initiated coverage on shares of Humana in a report on Wednesday, April 9th. They set a "buy" rating and a $326.00 target price for the company. Cantor Fitzgerald restated a "neutral" rating and issued a $290.00 price target on shares of Humana in a research note on Wednesday, February 12th. JPMorgan Chase & Co. reduced their price objective on Humana from $257.00 to $256.00 and set a "neutral" rating for the company in a research report on Tuesday, February 18th. Finally, Piper Sandler boosted their target price on Humana from $270.00 to $288.00 and gave the stock a "neutral" rating in a report on Wednesday, January 15th. Seventeen equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company's stock. According to MarketBeat.com, the company presently has a consensus rating of "Hold" and an average target price of $284.90.

Humana Stock Performance

Shares of NYSE HUM traded down $21.20 during midday trading on Friday, hitting $264.41. 3,670,273 shares of the company's stock traded hands, compared to its average volume of 1,759,722. The firm has a fifty day moving average of $265.90 and a 200 day moving average of $270.03. Humana Inc. has a 1 year low of $213.31 and a 1 year high of $406.46. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.76 and a current ratio of 1.76. The stock has a market capitalization of $31.91 billion, a price-to-earnings ratio of 26.57, a price-to-earnings-growth ratio of 2.05 and a beta of 0.62.

Humana (NYSE:HUM - Get Free Report) last issued its quarterly earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share for the quarter, topping the consensus estimate of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. On average, analysts forecast that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 25th. Investors of record on Friday, June 27th will be paid a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.34%. Humana's dividend payout ratio (DPR) is presently 35.58%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.